A Genome-Wide Association Study of Total Bilirubin and Cholelithiasis Risk in Sickle Cell Anemia-Reference-Cited by-同舟云学术

A Genome-Wide Association Study of Total Bilirubin and Cholelithiasis Risk in Sickle Cell Anemia

Published:2012-04-27 Issue:4 Volume:7 Page:e34741
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Milton Jacqueline N.,Sebastiani Paola,Solovieff Nadia,Hartley Stephen W.,Bhatnagar Pallav,Arking Dan E.,Dworkis Daniel A.,Casella James F.,Barron-Casella Emily,Bean Christopher J.,Hooper W. Craig,DeBaun Michael R.,Garrett Melanie E.,Soldano Karen,Telen Marilyn J.,Ashley-Koch Allison,Gladwin Mark T.,Baldwin Clinton T.,Steinberg Martin H.,Klings Elizabeth S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Surgical and obstetric outcomes in adults with sickle cell disease.;S Adam;Am J Med,2008

2. Risk factors for hyperbilirubinemia and gallstones in Chinese patients with beta thalassemia syndrome.;WY Au;Haematologica,2003

3. Hyperbilirubinemia and cholelithiasis in Chinese patients with hemoglobin H disease.;WY Au;Ann. Hematol,2005

4. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.;CP Strassburg;J. Biol. Chem,1998

5. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.;N Vasavda;Br. J. Haematol.,2007

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of <em>UGT1A1</em> gene sequencing in individuals with the Gilbert syndrome phenotype;Bulletin of Siberian Medicine;2024-07-10

2. Gilbert syndrome in patients with inherited hemolytic anemia modifies the clinical phenotype;Pediatric Hematology Oncology Journal;2024-06

3. Genetic Variation and Sickle Cell Disease Severity;JAMA Network Open;2023-10-18

4. Gilbert syndrome as a risk factor for the development of cholelithiasis in children;Srpski arhiv za celokupno lekarstvo;2023

5. Genetic Modifiers of Sickle Cell Disease;Hematology/Oncology Clinics of North America;2022-12